Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedMay 29, 2024
DataAggregated Company Financials
Companies12
  • 7D1.4%
  • 3M11.1%
  • 1Y2.9%
  • YTD11.7%

The Life Sciences industry has stayed flat over the last week. As for the the longer term, the industry is up 5.0% over the past 12 months. Earnings are forecast to grow by 47% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 29 May 2024kr42.2bkr16.3b-kr1,188,686,510.0060.3x-35.5x2.6x
Fri, 26 Apr 2024kr37.0bkr16.3b-kr1,244,732,213.0035.5x-29.7x2.3x
Sun, 24 Mar 2024kr38.8bkr16.0b-kr1,122,792,210.0036x-34.6x2.4x
Tue, 20 Feb 2024kr40.8bkr16.1b-kr1,406,407,350.0047.3x-29x2.5x
Thu, 18 Jan 2024kr36.4bkr15.5b-kr1,393,723,683.0044x-26.1x2.4x
Sat, 16 Dec 2023kr38.2bkr15.5b-kr1,393,723,683.0047.6x-27.4x2.5x
Mon, 13 Nov 2023kr31.2bkr15.4b-kr1,256,647,710.0034x-24.8x2x
Wed, 11 Oct 2023kr26.5bkr15.1b-kr1,134,516,711.0035.7x-23.4x1.8x
Fri, 08 Sep 2023kr29.2bkr15.1b-kr1,133,713,072.0038.1x-25.8x1.9x
Sun, 06 Aug 2023kr32.1bkr15.1b-kr213,871,038.0046.7x-150.2x2.1x
Tue, 04 Jul 2023kr36.3bkr14.6b-kr172,476,038.0035.9x-210.7x2.5x
Thu, 01 Jun 2023kr38.8bkr14.6b-kr173,602,038.0038.8x-223.4x2.6x
Sat, 29 Apr 2023kr36.4bkr14.5b-kr138,425,459.0035x-262.9x2.5x
Mon, 27 Mar 2023kr31.9bkr14.6b-kr57,185,459.0031x-557.6x2.2x
Wed, 22 Feb 2023kr40.2bkr14.4bkr826.4m35.4x48.6x2.8x
Fri, 20 Jan 2023kr38.5bkr14.2bkr943.9m38.1x40.8x2.7x
Sun, 18 Dec 2022kr39.4bkr14.1bkr944.3m41.5x41.7x2.8x
Tue, 15 Nov 2022kr39.6bkr14.1bkr936.8m41.4x42.3x2.8x
Thu, 13 Oct 2022kr32.3bkr13.5bkr750.9m47.7x42.9x2.4x
Sat, 10 Sep 2022kr38.4bkr13.5bkr751.3m55.5x51.1x2.8x
Mon, 08 Aug 2022kr43.7bkr13.2bkr667.8m44.6x65.4x3.3x
Wed, 06 Jul 2022kr44.7bkr13.2bkr753.4m39.3x59.3x3.4x
Fri, 03 Jun 2022kr54.8bkr13.2bkr753.4m48.2x72.8x4.1x
Sun, 01 May 2022kr53.3bkr12.7bkr742.5m51.9x71.8x4.2x
Tue, 29 Mar 2022kr61.7bkr11.8bkr746.3m54.4x82.6x5.2x
Thu, 24 Feb 2022kr50.6bkr11.4bkr784.8m43.3x64.5x4.4x
Sat, 22 Jan 2022kr66.8bkr10.8bkr786.3m44.8x85x6.2x
Mon, 20 Dec 2021kr79.5bkr10.8bkr786.3m51.5x101.1x7.4x
Wed, 17 Nov 2021kr88.7bkr10.8bkr788.5m54.4x112.4x8.2x
Fri, 15 Oct 2021kr93.7bkr9.9bkr853.6m55.4x109.8x9.5x
Sun, 12 Sep 2021kr102.5bkr9.9bkr853.6m58.5x120.1x10.4x
Tue, 10 Aug 2021kr90.3bkr9.9bkr853.6m48.7x105.8x9.2x
Price to Earnings Ratio

87.5x


Total Market Cap: kr74.6bTotal Earnings: kr852.0mTotal Revenue: kr8.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -19.5x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 4.1x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 24% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.60%
Healthcare1.24%
Life Sciences1.38%
Clinical Research and Equipment1.38%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifekr112.502.3%
+kr304.7m
-15.4%PE175.8x
BIOT Biotagekr178.001.3%
+kr184.0m
23.2%PE60.3x
PRO Promimickr33.3024.3%
+kr121.3m
18.9%PS14.8x
BICO BICO Groupkr45.542.3%
+kr72.0m
-21.1%PS1.3x
MAGLE Magle Chemoswed Holdingkr33.400.6%
+kr2.2m
0%PE29.5x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOT

kr178.00

Biotage

7D

1.3%

1Y

23.2%

BICO

kr45.54

BICO Group

7D

2.3%

1Y

-21.1%

PEXA B

kr0.40

PExA

7D

-7.7%

1Y

-32.5%

CLINE B

kr0.08

Cline Scientific

7D

-20.4%

1Y

-73.9%

GENO

kr35.05

Genovis AB (publ.)

7D

-2.0%

1Y

-32.6%

AROC

kr0.41

AroCell

7D

1.3%

1Y

-34.7%

ATANA

kr0.094

Attana

7D

-7.8%

1Y

-42.0%

PRO

kr33.30

Promimic

7D

24.3%

1Y

18.9%

LEVBIO

kr0.32

Level Bio

7D

-3.0%

1Y

-46.7%